Original Research

Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma

Cheng Z, Amin M, van Brakel M, Sacchetti A, Kim RQ, Seynhaeve ALB, Debets R, ten Hagen TLM

International Journal of Nanomedicine 2026, 21:561111

Published Date: 12 January 2026